Lv41
646 积分 2024-11-23 加入
Impact of Daratumumab Rescue Therapy on Peripheral-Blood and Graft-Infiltrating Immune Cells in Kidney Transplant Antibody-Mediated Rejection
46分钟前
求助中
Evaluation of Safety Outcomes of Daratumumab for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients
52分钟前
已完结
From Rejection to Recovery: Daratumumab for Treatment of Antibody Mediated Rejection (AbMR) in Kidney Transplantation (KT)
52分钟前
求助中
Efficacy of Daratumumab in Treating Microvascular Inflammation (MVI) in Kidney Allograft Rejection
52分钟前
求助中
Subcutaneous Daratumumab Demonstrates Safety and Efficacy in Treating Antibody-Mediated Rejection in Kidney Transplant Recipients: A Case Series
53分钟前
求助中
Real-World Single-Center Experience of Daratumumab-Based Therapy for Antibody-Mediated Rejection in Kidney Transplantation
53分钟前
求助中
Daratumumab for Refractory Chronic Antibody Mediated Rejection in Kidney Transplant
54分钟前
求助中
Daratumumab for Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: A Case Series
56分钟前
已完结
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
2个月前
已完结
A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial
4个月前
已完结
皖公网安备34019202002308
